Mannkindoration (MNKD) 2.33 -0.08

Mannkind Corporation
(MNKD) 2.33 -0.08

Last Trade:	2.33	Day Range:	2.25 - 2.3825
Trade Time:	08:02PM	52wk Range:	2.14 - 5.42
Prev. Close:	2.41	Market Cap:	306.02M
Open:	2.37	Div Yield:	0
Volume:	2030748	PE:	-20
EPS:	-1.35

The Latest On MNKD

MannKind Announces Exercise In Full of Over-Allotment Option and Completion of Public Offering 2/8/12 5:01pm

From Earlier: MannKind Receives Commitment from The Mann Group to Acquire 31.25M Shares of Common Stock 2/3/12 7:08am

From Earlier: MannKind Announces Pricing of Public Offering of Units Consisting of Common Stock and Warrants to Purchase Common Stock 2/3/12 7:07am

MannKind Announces Pricing of Public Offering of 31.25M Units Consisting of Common Stock at $2.40/Unit 2/3/12 6:56am

UPDATE: MannKind Corporation Announces $161M Senior Secured Note Offering at $3.00/Share -Filing 1/31/12 10:55am

MannKind Announces Proposed Public Offering of $50M Common Stock and Warrants to Purchase Common Stock 1/31/12 9:52am

Option Alert: Mannkind Januaru 2013 3 Call; Block Trade, 4,033 Contracts 1/20/12 2:37pm

Why we remain bullish on Mannkind 1/18/12 2:01am

MannKind Resolves All Claims in Arbitration with Former Employee 12/13/11 4:15pm

Notable Put Options Activity in MannKind 10/12/11 10:13am

Friday's NASDAQ Winners: Harleysville Group, MannKind, American Superconductor, Syms 9/26/11 10:18am

A Peek Into The Market Before The Trading Starts 9/23/11 7:34am

MannKind Announces Exercise In Full of Over-Allotment Option and Completion of Public Offering 2/8/12

From Earlier: MannKind Receives Commitment from The Mann Group to Acquire 31.25M Shares of Common Stock 2/3/12

From Earlier: MannKind Announces Pricing of Public Offering of Units Consisting of Common Stock and Warrants to Purchase Common Stock 2/3/12

MannKind Announces Pricing of Public Offering of 31.25M Units Consisting of Common Stock at $2.40/Unit 2/3/12

UPDATE: MannKind Corporation Announces $161M Senior Secured Note Offering at $3.00/Share -Filing 1/31/12

MannKind Announces Proposed Public Offering of $50M Common Stock and Warrants to Purchase Common Stock 1/31/12

Option Alert: Mannkind Januaru 2013 3 Call; Block Trade, 4,033 Contracts 1/20/12

Why we remain bullish on Mannkind 1/18/12

MannKind Resolves All Claims in Arbitration with Former Employee 12/13/11

Notable Put Options Activity in MannKind 10/12/11

Friday's NASDAQ Winners: Harleysville Group, MannKind, American Superconductor, Syms 9/26/11

A Peek Into The Market Before The Trading Starts 9/23/11

Friday's NASDAQ Winners: Harleysville Group, MannKind, American Superconductor, Syms 9/26/11

Friday's NASDAQ Winners: Clearwire, Sky-Mobi, MannKind, TranSwitch 8/15/11

Can You Help Save Mannkind? 8/12/11

Stocks to Watch for Wednesday 8/03/2011: Fresh 52 Week Highs and Lows 8/3/11

Stocks to Watch for Tuesday 8/02/2011: Fresh 52-Week Highs and Lows 8/2/11

Stocks to Watch for Thursday 7/28/2011: Fresh 52 Week Highs and Lows 7/28/11

Top Percentage Gainers and Losers as of 2pm 6/28/11 6/28/11

Mad Money Lightning Round OT: Cramer Is Bearish On MNKD (ULTA, MNKD, RFMD, SWKS, OVTI) 6/7/11

Top Percentage Gainers and Losers as of 2pm 5/10/11 (FONR, CKXE, TRAK, CPE, SREV, FFHL, MED, FOSL, BMTI, HEAT, PANL, MOBI, MNKD, VRML, USAT, ETM) 5/10/11

Stocks To Watch For May 10 (DIS, MNKD, MDR, MSFT, WEN) 5/10/11

Mannkind Spikes Higher on JMP Securities Upgrade to Buy and $7PT 8/12/11

Rodman & Renshaw Maintains Market Perform on MannKind 8/5/11

Rodman & Renshaw Reiterates Market Perform on MannKind 7/11/11

Hapoalim Securities Terminates Healthcare Coverage Including Bristol-Myers, Eli Lilly, Merck and Pfizer 6/1/11

Hapoalim Cutting Ocverage On Multitude Of Names 6/1/11

Hapoalim Reiterating Sell On MannKind (MNKD) 5/10/11

J.P. Morgan Maintains Underweight on MannKind (MNKD) 5/10/11

Hapoalim Reiterates Sell Rating On MNKD 4/11/11

Hapoalim Reiterates Sell on MannKind (MNKD) 2/11/11

MannKind Downgraded to Market Perform at Rodman & Renshaw (MNKD) 1/20/11

Wells Fargo Downs MNKD To Market Perform 1/20/11

Wells Fargo Cuts Estimates On ManKind (MNKD) 12/30/10

Trade MNKD
NOW!

Partner Headlines

These 4 Biotech Stocks Are a Buy Now 2/8/12

The Details of the Afrezza Approval Delay 1/31/12

MannKind's Afrezza Was to Be Approved; What Happened Next? 1/30/12

Why MannKind Should Merit Your Attention 1/30/12

Why MannKind merits your attention? 1/30/12

MannKind Treads the Neutral Path - Analyst Blog 1/27/12

5 Speculative Biotech Stocks to Consider Buying Now 1/24/12

Biotech Stock Mailbag: Celldex, Hep C Bubble, Al Mann Anger 1/20/12

Your Vote Counts: Who is the Worst Biotech CEO of 2011? 12/1/11

MannKind in Neutral Lane - Analyst Blog 11/28/11

MannKind Narrows Loss - Analyst Blog 11/4/11

Press Releases

MannKind Announces Exercise In Full of Over-Allotment Option and Completion of Public Offering of Units Consisting of Common Stock and Warrants to Purchase Common Stock 2/8/12 Business Wire Story

MannKind to Present at Upcoming Conferences 2/7/12 Business Wire Story

MannKind Receives Commitment from The Mann Group to Acquire 31,250,000 Shares of Common Stock 2/2/12 Business Wire Story

MannKind Announces Pricing of Public Offering of Units Consisting of Common Stock and Warrants to Purchase Common Stock 2/2/12 Business Wire Story

MannKind Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock 1/31/12 Business Wire Story

MannKind to Present at 30th Annual J.P. Morgan Healthcare Conference 1/5/12 Business Wire Story

Dicerna Pharmaceuticals Appoints Life Sciences Executive James B. Weissman to Chief Business Officer 1/4/12 Business Wire Story

MannKind Resolves All Claims in Arbitration with Former Employee 12/13/11 Business Wire Story

MannKind to Present at Upcoming Conferences 11/8/11 Business Wire Story

MannKind Corporation Reports 2011 Third Quarter Financial Results 11/3/11 Business Wire Story

EGOC, DUSS, NYXO, TOFS, MNKD Are Penny Stocks in Review by Undiscovered Equities.com For Coming Week 9/24/11 Emailwire Story

MannKind Corporation to Hold 2011 Third Quarter Financial Results Conference Call on November 3, 2011 8/30/11 Business Wire Story

Get the latest MNKD stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Mannkind Corporation stock price.

Mannkind Corporation by YCharts

Mannkindoration (MNKD) 2.33 -0.08

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On MNKD

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social